Heart Failure Medications Zachary Cox, PharmD Associate Professor Lipscomb University College of Pharmacy Clinical Pharmacist, Vanderbilt University Medical.

Slides:



Advertisements
Similar presentations
BACK TO BASICS: PHARMACOLOGY CHAD C. CRIPE, MD Department of Anesthesiology & Critical Care Medicine Division of Cardiothoracic Anesthesiology The Children’s.
Advertisements

Heart Failure Management Focus on Primary Care Practice.
ACEIs, ARBs, or DRI for Adults With Hypertension Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
Cardiac medications. Anticoagulants  Commonly prescribed include: Dalteparin (Fragmin), Danaparoid (Orgaran), Enoxaparin (Lovenox), Heparin (various),
Dr. Jon Salisbury Visiting Physician Services A Member of VNA Health Group No Disclosures May 14, :40PM – 2:00PM ©AAHCM.
Antihypertensives Chad Byworth. Hypertension What is hypertension? Blood pressure of greater than 140 systolic or 90 diastolic, confirmed in primary care.
CARDIVASCULAR DRUGS Sanjukta (2009). CARDIOVASCULAR DISEASE AND DRUGS ► Basic cardiovascular physiology and pathology depends on the control of heart.
Pharmacologic Treatment of Chronic Systolic Heart Failure John N. Hamaty D.O. FACC, FACOI.
Heart Failure and Qof Quiz Justin Walker October 2010.
Heart Failure Medicines ACE (angiotensin- converting enzyme) inhibitors ARBs (angiotensin receptor blockers) Beta-blockers Spironolactone Diuretics (water.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Systolic CHF Therapy Rogers Kyle, MD 10/2/12. Learning Objectives Review the staging and evaluation of patients with systolic heart failure Review the.
U 1. 2 CONGESTIVE HEART FAILURE Is a complex, progressive disorder in which the heart is unable to pump sufficient blood to meet the demands of the body.
Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal
 Hypertension : BPDIASTOLIC SYSTOLIC Normal< 130< 85 Mild hypertension Moderate hypertension Severe Hypertension 180.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
2013 American College of Cardiology American Heart Association.
Patient case studies. JR is a 72 YO male with CHF, LVEF=32%. T2DM, HTN His meds include carvedilol 12.5mg q12hr, furosemide 40mg q day, and kcl 20meq.
Compliance with clinical practice guidelines for the treatment and optimization of therapy in heart failure patients in outpatient medicine clinics MaryAnn.
Antihypertensives Dr Thabo Makgabo.
Pharmacology of Heart failure
Drug List Accupril Quinapril – ACE Inhibitor – HTN & CHF.
Heart Failure. Background to Congestive Heart Failure Normal cardiac output needed to adequately perfuse peripheral organs – Provide O 2, nutrients, etc.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Online additional material Appendix Table 1: Medications Groups Appendix Table 2: Doctors' orders in hemodialysis units Additional Figure 1: Beta Blockers.
A History of Dropsy: From Edema to Transplant
Sara Paul DNP, FNP Catawba Valley Cardiology Conover, NC.
Hypertension Treatment Dr.Negin Nezarat. 1.mechanisms and cardiovascular pathophysiology (Review). 2.major forms of clinical hypertension. 3.major classes.
CURRENT APPROACH TO THE TREATMENT OF CONGESTIVE HEART FAILURE.
Clinical Pharmacology of Drugs for Controlling Vascular Tone
Hypertension Hypertension can be classified as follows: Mild :Diastolic pressure mmHg Moderate: Diastolic pressure mmHg Sever: Diastolic pressure.
Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial.
CVS PHARMACOLOGY. Drugs to treat myocardial ischemia Etiology 1. Decrease in myocardial oxygen supply [determined by oxygen-carrying capacity of blood.
CHF Team Approach Peter Carson, MD Jacqueline Gannuscio, MSN, ACNP RN Washington DC.
Heart Failure: medication Types of Heart Failure Systolic (or squeezing) heart failure –Decreased pumping function of the heart, which results in fluid.
Pharmacology of Renin-Angiotensin system
Effect of some adrenergic drugs and its blockers on the blood pressure.
Decreasing the Load After the Fill May the Force be with you Clearing the Path Let it Flow
Management of Heart Failure Dr. M.Kheir Mulki. What is the definition of Heart Failure ?
Conivaptan -vaptan = Vasopressin receptor antagonist.
Heart Failure J. Lynn Davis, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April 25, 2015.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
MEDICINES & THE HEART. Medicines & the Heart You and your medicines You and your medicines Common heart medicines for preventing heart disease Common.
Internal Medicine Workshop Series Laos September /October 2009.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
HF diagnosis: audit of NTproBNP uptake and outcomes across Sheffield An update on diagnosis and management of HF Dr Abdallah Al-Mohammad, MD, FRCP(Edin),
Pharmacology of Heart Failure Treatments: Part 1
Kristina Zurita, RN Heart Failure Unit Florida Hospital 2013.
POTASSIUM-SPARING DIURETICS 1.Aldosterone antagonists: Spironolactone and eplerenone: The spironolactone-receptor complex is inactive complex results in.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
Resistant Hypertension Topic Discussion Brian Skinner, PharmD PGY-1 Pharmacy Resident St. Vincent Indianapolis Hospital.
What’s New in Heart Failure
No relevant financial relationships to disclose
Heart Failure in Women Dr. Jennifer Haythe
Heart Failure By Alaina Darby.
Heart Failure By Alaina Darby.
ANTI-HYERTENSIVE DRUGS: Therapeutic overview
Heart Failure - Summary
Management of Heart Failure
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Review of Cardiovascular and Renal Drugs
Fig. 2. Evidence-based medication prescriptions
Heart Failure through the Ages
Internal Medicine Workshop Series Laos September /October 2009
Drugs used in treatment of Heart failure II
Presentation transcript:

Heart Failure Medications Zachary Cox, PharmD Associate Professor Lipscomb University College of Pharmacy Clinical Pharmacist, Vanderbilt University Medical Center

Medications in HF ACE Inhibitors (ACEIs) Angiotensin Receptor Blockers (ARBs) Beta BlockersAldosterone Antagonists Captopril Benazepril Enalapril Fosinopril Lisinopril Perindopril Quinapril Ramipril Trandolapril Candesartan Losartan Valsartan Bisoprolol Carvedilol Carvedilol CR Metoprolol XL Spironolactone Eplerenone

Medication Differences by Ejection Fraction Systolic HF (HF r EF) Diastolic HF (HF p EF) Medication StudiesMany Studies Positive Results Fewer Studies Frustrating Results Medication OutcomesIncreased Length of Life Less Hospitals Visits Less Hospital Visits Medication GoalsSpecific DosesSymptom Control Blood Pressure Control Medications that improve HF outcomes ACEI, ARB, Valsartan/Sacubitril, Beta Blocker, Aldosterone Antagonist, Hydralazine/Nitrate, Ivadrabine, Digoxin ARBs Spironolactone

Symptom Control Hospital Avoidance Increased length of life ACE Inhibitors -OR- ARBs -OR- Sacubitril/ Valsartan -OR- Hydralazine + Nitrates ACE Inhibitors -OR- ARBs -OR- Sacubitril/ Valsartan -OR- Hydralazine + Nitrates Beta Blockers Carvedilol -OR- Metoprolol XL -OR- Bisoprolol Beta Blockers Carvedilol -OR- Metoprolol XL -OR- Bisoprolol Aldosterone Antagonists Spironolactone -OR- Eplerenone Aldosterone Antagonists Spironolactone -OR- Eplerenone

Additional Symptom Control Loop Diuretics Bumetanide Furosemide Torsemide Ethacrynic Acid HF Medications Digoxin Ivabradine Nitrates Tolvaptan Disease States Heart Rhythm Heart Arteries Heart Valves Diabetes Cholesterol Blood Pressure Sleep Apnea Kidney Disease Lung Diseases

Loop Diuretics Threshold EffectDuration of Effect Hours Hours DIURETIC

Multiple Providers & Conflicting Advice HF patients with Medicare see an average of 15 providers a year and have 8 different prescribers 17% report conflicting advice from doctors 22% of HF patients taking wrong medications received conflicting medication instructions 2/3 HF patients have 2-3 different diets State of the Science: Promoting Self-Care in Persons with Heart Failure. Circulation 2009;120:

Medications to Avoid in HF Diltiazem/Verapamil Itraconazole Cilostazol Flecanide Propafenone Pioglitazone/Rosiglitazon e Minoxidil Dronedarone ADHD Medications NSAIDs – Ibuprofen – Naproxen – Celecoxib – Meloxicam – Diclofenac TNF Alpha Inhibitors – Infliximab (Remicade) – Etanercept (Enbrel) – Adalimumab (Humira)

Medication Adherence 1.Forgetful or Busy 2.Access to Pharmacy 3.Perception Benefit Risks 4.Organization Administration times Refill dates 1.Reminder Alerts 2.Home Delivery 3.Initiate Conversation Real outcomes Odds of adverse event Individualized risk BarriersSolutions

Medication Organization Levothyroxine Furosemide Enalapril Carvedilol Hydralazine Isosorbide Dinitrate Hydralazine Isosorbide Dinitrate Furosemide Carvedilol Hydralazine Isosorbide Dinitrate Enalapril Atorvastatin Furosemide Enalapril Carvedilol Hydralazine Isosorbide Dinitrate Furosemide Hydralazine Isosorbide Dinitrate Atorvastatin Enalapril Carvedilol Hydralazine Isosorbide Dinitrate Levothyroxine 6 AM7 AMNoon3 PM6 PM10 PM 7 AM3 PM10 PM